In this retrospective study, researchers explored mortality among women with breast cancer in states with and without Medicaid expansion.

Investigator sought to determine whether nelfinavir mesylate plus chemoradiation and image-guided brachytherapy could improve disease-free survival for patients with stage III cervical cancer.

Lack of knowledge or inaccurate beliefs, active avoidance or lack of trust, infrastructure gaps identified as barriers ...

Decrease seen in percent of patients receiving timely treatment among those living in states with least stringent regulations ...

The NCCN’s updated guidelines for the treatment of breast cancer include updates on sentinel lymph node biopsy, ovarian function suppression, and the use of prognostic tools.

(HealthDay News) — For the five leading causes of cancer-related death in people younger than 50 years, mortality decreased from 1990 through 2023, except for colorectal cancer (CRC), according to a ...

Darzalex Faspro is a subcutaneous formulation that combines daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase.

Investigators used the SEER-Medicare claims linked database to explore the persistence of racial-ethnic disparities in pain treatment among survivors of cancer.

Ensemble integrating three architectures achieved area under the curve of 0.9208, outperforming individual models ...

(HealthDay News) — Federal officials have lifted a short pause on more than 100 public health grants worth over $5 billion, allowing states to continue work aimed at strengthening health systems.

(HealthDay News) — The United States has officially pulled out of the World Health Organization (WHO), a year after President Donald Trump announced plans to leave the global health group.

To evaluate the clinical benefit of extended endocrine therapy after 5 years of adjuvant treatment with LHRHa in premenopausal women with node-positive, HR-positive early breast cancer.